116 related articles for article (PubMed ID: 38218690)
1. The aMAP score predicts long-term outcomes after resection of hepatocellular carcinoma: a multi-institutional analysis.
Tsilimigras DI; Endo Y; Ratti F; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Kitago M; Guglielmi A; Hugh T; Aldrighetti L; Gleisner A; Shen F; Endo I; Pawlik TM
HPB (Oxford); 2024 Apr; 26(4):541-547. PubMed ID: 38218690
[TBL] [Abstract][Full Text] [Related]
2. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria.
Ohama H; Hiraoka A; Tada F; Kato K; Fukunishi Y; Yanagihara E; Kato M; Saneto H; Izumoto H; Ueki H; Yoshino T; Kitahata S; Kawamura T; Kuroda T; Suga Y; Miyata H; Hirooka M; Abe M; Matsuura B; Ninomiya T; Hiasa Y
Oncology; 2023; 101(9):575-583. PubMed ID: 37459848
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify.
Johnson PJ; Innes H; Hughes DM; Kalyuzhnyy A; Kumada T; Toyoda H
Br J Cancer; 2022 Oct; 127(7):1263-1269. PubMed ID: 35798825
[TBL] [Abstract][Full Text] [Related]
5. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
Fan R; Papatheodoridis G; Sun J; Innes H; Toyoda H; Xie Q; Mo S; Sypsa V; Guha IN; Kumada T; Niu J; Dalekos G; Yasuda S; Barnes E; Lian J; Suri V; Idilman R; Barclay ST; Dou X; Berg T; Hayes PC; Flaherty JF; Zhou Y; Zhang Z; Buti M; Hutchinson SJ; Guo Y; Calleja JL; Lin L; Zhao L; Chen Y; Janssen HLA; Zhu C; Shi L; Tang X; Gaggar A; Wei L; Jia J; Irving WL; Johnson PJ; Lampertico P; Hou J
J Hepatol; 2020 Dec; 73(6):1368-1378. PubMed ID: 32707225
[TBL] [Abstract][Full Text] [Related]
6. Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures.
Fan R; Chen L; Zhao S; Yang H; Li Z; Qian Y; Ma H; Liu X; Wang C; Liang X; Bai J; Xie J; Fan X; Xie Q; Hao X; Wang C; Yang S; Gao Y; Bai H; Dou X; Liu J; Wu L; Jiang G; Xia Q; Zheng D; Rao H; Xia J; Shang J; Gao P; Xie D; Yu Y; Yang Y; Gao H; Liu Y; Sun A; Jiang Y; Yu Y; Niu J; Sun J; Wang H; Hou J
J Hepatol; 2023 Oct; 79(4):933-944. PubMed ID: 37302583
[TBL] [Abstract][Full Text] [Related]
7. [Application of aMAP score to assess the risk of hepatocarciongenesis in population of chronic liver disease in primary hospitals].
Li XH; Hao X; Deng YH; Liu XQ; Liu HY; Zhou FY; Fan R; Guo YB; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):332-337. PubMed ID: 33979959
[No Abstract] [Full Text] [Related]
8. Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study.
Xin Y; Zhang X; Yang Y; Chen Y; Wang Y; Zhou X; Li X
J Gastrointest Oncol; 2021 Dec; 12(6):2930-2942. PubMed ID: 35070419
[TBL] [Abstract][Full Text] [Related]
9. External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy.
Gui H; Huang Y; Zhao G; Chen L; Cai W; Wang H; Guo Q; Xie Q
Front Med (Lausanne); 2021; 8():677920. PubMed ID: 34422855
[No Abstract] [Full Text] [Related]
10. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
[TBL] [Abstract][Full Text] [Related]
12. Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.
Yang T; Hu LY; Li ZL; Liu K; Wu H; Xing H; Lau WY; Pawlik TM; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Li C; Wang MD; Wu MC; Shen F
J Gastrointest Surg; 2020 Feb; 24(2):320-329. PubMed ID: 30617773
[TBL] [Abstract][Full Text] [Related]
13. Perioperative Lymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following Hepatectomy for Hepatocellular Carcinoma.
Tsilimigras DI; Endo Y; Ratti F; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Kitago M; Guglielmi A; Hugh T; Aldrighetti L; Gleisner A; Shen F; Endo I; Pawlik TM
Ann Surg Oncol; 2024 Apr; 31(4):2568-2578. PubMed ID: 38180707
[TBL] [Abstract][Full Text] [Related]
14. The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study.
Chen Y; Shi Y; Lu L; Wang X; Lin Q; Lin Y; Wang R; Zhu H; Zheng P; Chen X
J Cancer; 2023; 14(8):1272-1281. PubMed ID: 37283795
[No Abstract] [Full Text] [Related]
15. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
16. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
17. aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C.
Yamashita Y; Joshita S; Sugiura A; Yamazaki T; Kobayashi H; Wakabayashi SI; Yamada Y; Shibata S; Kunimoto H; Iwadare T; Matsumura M; Miyabayashi C; Okumura T; Ozawa S; Nozawa Y; Kobayashi N; Komatsu M; Fujimori N; Saito H; Umemura T
Hepatol Res; 2021 Sep; 51(9):933-942. PubMed ID: 34216422
[TBL] [Abstract][Full Text] [Related]
18. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
[TBL] [Abstract][Full Text] [Related]
19. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Estimated Risk of Microvascular Invasion is Associated with Prognostic Differences Following Liver Resection Versus Radiofrequency Ablation for Early Hepatitis B Virus-Related Hepatocellular Carcinoma.
Bai S; Yang P; Xie Z; Li J; Lei Z; Xia Y; Qian G; Zhang B; Pawlik TM; Lau WY; Shen F
Ann Surg Oncol; 2021 Dec; 28(13):8174-8185. PubMed ID: 34409542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
